Sumitomo Mitsui Ds Asset Management Company, LTD Moderna, Inc. Transaction History
Sumitomo Mitsui Ds Asset Management Company, LTD
- $7.99 Billion
- Q1 2024
A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Moderna, Inc. stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 32,775 shares of MRNA stock, worth $3.84 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
32,775
Previous 28,969
13.14%
Holding current value
$3.84 Million
Previous $2.88 Million
21.25%
% of portfolio
0.04%
Previous 0.04%
Shares
16 transactions
Others Institutions Holding MRNA
# of Institutions
1,037Shares Held
245MCall Options Held
12.1MPut Options Held
9.36M-
Baillie Gifford & CO44.7MShares$5.23 Billion3.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA39MShares$4.57 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY25.4MShares$2.97 Billion0.06% of portfolio
-
State Street Corp Boston, MA14.5MShares$1.69 Billion0.07% of portfolio
-
Flagship Pioneering Inc. Cambridge, MA9.67MShares$1.13 Billion67.87% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $45.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...